1. Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. EUR-Lex website. https://eur-lex.europa.eu/eli/dir/2013/59/oj. Published December 5, 2013. Accessed August 20, 2024.
2. Implementation of dosimetry for molecular radiotherapy; results from a European survey;Peters;Phys Med.,2024
3. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
4. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
5. Assessment report: LUTATHERA. EMA website. www.ema.europa.eu/en/documents/assessment-report/lutathera-epar-public-assessment-report_en.pdf. Published July 20, 2017. Accessed August 20, 2024.